Eli Lilly (NYSE:LLY) Advances Alopecia Study Results Amid 4% Share Price Rise
Eli Lilly (NYSE:LLY) has recently unveiled significant advancements across its product line, including promising results from ...
Eli Lilly-Incyte Partnered FDA-Approved Drug Shows Encouraging Efficacy In Adolescent Patients With Patchy Hair Loss
Eli Lilly And Co (NYSE:LLY) and Incyte Corporation (NASDAQ:INCY) said adolescent patients with severe alopecia areata (AA) ...
Incyte, Eli Lilly present results from Phase 3 BRAVE-AA-PEDS study
Late-breaking results from Eli Lilly and Company (LLY) and Incyte (INCY) found adolescent patients with severe alopecia areata, AA, treated ...
Healio2d
Baricitinib effective in adolescents with severe alopecia areata, phase 3 data show
Thirty-six weeks of once-daily, oral baricitinib was associated with greater hair regrowth on the scalp, eyebrows and ...
Managed Healthcare Executive2d
Medicaid Coverage of JAK Inhibitors for Alopecia is Limited | AAD 2025
Of the states that do provide coverage for JAK inhibitors used to treat patients with alopecia, researchers found that prior ...
Healthy Returns: Wegovy is linked to an increased risk of hair loss, study suggests
Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...
pharmaphorum6d
Pfizer’s alopecia drug gets EU nod, chasing Lilly’s Olumiant
Pfizer has picked up approval in the EU for Litfulo, its JAK inhibitor for severe alopecia areata, extending its challenge to Eli Lilly’s first-to-market Olumiant. The European Commission has ...
pharmaphorum4d
Pfizer’s Litfulo becomes first NHS drug for alopecia areata
The decision comes a few months after the first drug to be approved in the UK for alopecia – Eli Lilly’s JAK1/2 inhibitor Olumiant (baricitinib) – was turned down. Olumiant was cleared by ...
Le Lézard6d
Quebec becomes first province to publicly reimburse APRETUDE for HIV-1 Pre-Exposure Prophylaxis (PrEP)
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce that Quebec has become the first ...